Your gateway to a free society
Article

Here's All The Key Figures Who Have Resigned Over The Epstein Files...So Far

Here's All The Key Figures Who Have Resigned Over The Epstein Files...So Far We are starting to finally see the beginning of a series of high-profile resignations following the Justice Department’s latest release of millions of pages tied to convicted sex offender Jeffrey Epstein. The documents—emails, financial records, and photographs—name figures from politics, finance, diplomacy, academia, and the arts. Although inclusion in the files is not evidence of wrongdoing, the renewed scrutiny has prompted several prominent leaders to step down, as was documented by Time yesterday.  As we've covered individually, those who...
Back

aboutLiberty Portal

Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Feb 18, 2026 / Tyler Durden
Three Key Constraints That Could Derail The Data Center Buildout Story
Three Key Constraints That Could Derail The Data Center Buildout Story The data center investment macro story centers on hyperscalers such as Microsoft, Alphabet, Meta, and Amazon Web Services, whose massive cloud computing services are becoming the backbone for AI workloads, including ChatGPT and others. However, as we've previously noted, the data center buildout has run into supply-chain snarls, including memory chip shortages, power-grid constraints, and even a shortage of turbine blades for natural-gas generators. The data center boom powering the AI revolution is certaintly impressive to watch unfold, but it...
Read more
Feb 11, 2026 / blueapples
Massie Exposes Les Wexner As Epstein Co-Conspirator, Opening Door To Criminal Charges Against Kash Patel
Although President Donald J. Trump has amplified his attacks against Kentucky representative Thomas Massie on the basis of deluded claims that he is a radical, un-American liberal who is hellbent on sabotaging his administration, it is the congressman’s continued crusade to expose the crimes of Jeffrey Epstein that shows the actual threat he poses to […]
Read more
Feb 23, 2026 / Tyler Durden
"Worst-Case Scenario": Novo Nordisk Plunges After Next-Gen Obesity Drug Falls Short Of Lilly Rival
"Worst-Case Scenario": Novo Nordisk Plunges After Next-Gen Obesity Drug Falls Short Of Lilly Rival Shares of Novo Nordisk A/S plummeted again on Monday after the company reported trial results showing its next-generation obesity shot, CagriSema, delivered 20.2% weight loss at 84 weeks, compared to 23.6% for Eli Lilly & Co.’s tirzepatide (Zepbound). Bloomberg Intelligence analyst Michael Shah explained, "This outcome is the worst-case scenario for Novo and heightens the need for M&A with Novo’s other GLP-1/Amylin drug." Shares of Novo in Copenhagen plunged as much as 16.5%, breaking below a support level...
Read more

support

If you like what we do and want to support us, then you are a fine humanitarian. Click the link below to find out more.